Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strat...
Q3 2026
May 15, 2026
Q2 2026
Dec 31, 2025
Q1 2026
Sep 29, 2025
FY 2025
Jun 30, 2025
Q4 2025